These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2111126)

  • 1. Beneficial effect of enhanced macrophage function in the trauma patient.
    Browder W; Williams D; Pretus H; Olivero G; Enrichens F; Mao P; Franchello A
    Ann Surg; 1990 May; 211(5):605-12; discussion 612-3. PubMed ID: 2111126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
    Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enhanced macrophage function on early wound healing.
    Browder W; Williams D; Lucore P; Pretus H; Jones E; McNamee R
    Surgery; 1988 Aug; 104(2):224-30. PubMed ID: 3261048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: a correlation with the survival rate.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):277-84. PubMed ID: 9523001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
    Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less systemic cytokine response in patients following microendoscopic versus open lumbar discectomy.
    Huang TJ; Hsu RW; Li YY; Cheng CC
    J Orthop Res; 2005 Mar; 23(2):406-11. PubMed ID: 15734255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
    Mack Strong VE; Mackrell PJ; Concannon EM; Mestre JR; Smyth GP; Schaefer PA; Stapleton PP; Daly JM
    J Surg Res; 2001 Jun; 98(1):40-6. PubMed ID: 11368536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study.
    Schmidt SC; Hamann S; Langrehr JM; Höflich C; Mittler J; Jacob D; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2007; 14(5):484-92. PubMed ID: 17909718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effect of enhanced macrophage function on the healing of bowel anastomoses.
    Compton R; Williams D; Browder W
    Am Surg; 1996 Jan; 62(1):14-8. PubMed ID: 8540639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan).
    de Felippe Júnior J; da Rocha e Silva Júnior M; Maciel FM; Soares Ade M; Mendes NF
    Surg Gynecol Obstet; 1993 Oct; 177(4):383-8. PubMed ID: 8211583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
    Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
    Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects after inhalation of (1-->3)-beta-D-glucan in healthy humans.
    Thorn J; Beijer L; Rylander R
    Mediators Inflamm; 2001 Aug; 10(4):173-8. PubMed ID: 11577993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer.
    Mokart D; Capo C; Blache JL; Delpero JR; Houvenaeghel G; Martin C; Mege JL
    Br J Surg; 2002 Nov; 89(11):1450-6. PubMed ID: 12390391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study.
    Kirmaz C; Bayrak P; Yilmaz O; Yuksel H
    Eur Cytokine Netw; 2005 Jun; 16(2):128-34. PubMed ID: 15941684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of macrophage stimulation on collagen biosynthesis in the healing wound.
    Portera CA; Love EJ; Memore L; Zhang L; Müller A; Browder W; Williams DL
    Am Surg; 1997 Feb; 63(2):125-31. PubMed ID: 9012425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1-->3)-beta-D-glucan increases long-term survival in polymicrobial sepsis.
    Williams DL; Ha T; Li C; Kalbfleisch JH; Laffan JJ; Ferguson DA
    Surgery; 1999 Jul; 126(1):54-65. PubMed ID: 10418593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF).
    Joshi PC; Poole GV; Sachdev V; Zhou X; Jones Q
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):13-20. PubMed ID: 11334363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations of leucocyte migration activating factor with interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha in drug allergy].
    Sano N; Uno K
    Arerugi; 1998 Nov; 47(11):1198-204. PubMed ID: 9893337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.
    Babineau TJ; Marcello P; Swails W; Kenler A; Bistrian B; Forse RA
    Ann Surg; 1994 Nov; 220(5):601-9. PubMed ID: 7979607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.